Life Molecular Imaging announces Neuraceq® availability at PharmaLogic Salt Lake City

Seeking Alpha / 2 Views

Enhanced the supply capabilities of Neuraceq® to increase patient access to beta-amyloid PET imaging BOSTON, April 24, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI) and PharmaLogic Holdings Corp. (PharmaLogic), a world-class contract development and manufacturing organization (CDMO)...

Comments